Home
>
National Drug Code (NDC)
>
Zelapar
Zelapar - 0187-0453-02 - (selegiline hydrochloride)
Drug Information of Zelapar
| Product NDC: | 0187-0453 |
| Proprietary Name: | Zelapar |
| Non Proprietary Name: | selegiline hydrochloride |
| Active Ingredient(s): | 1.25 mg/1 & nbsp; selegiline hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zelapar
| Product NDC: | 0187-0453 |
| Labeler Name: | Valeant Pharmaceuticals International |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021479 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060614 |
Package Information of Zelapar
| Package NDC: | 0187-0453-02 |
| Package Description: | 6 POUCH in 1 CARTON (0187-0453-02) > 1 BLISTER PACK in 1 POUCH > 10 TABLET in 1 BLISTER PACK |
NDC Information of Zelapar
| NDC Code | 0187-0453-02 |
| Proprietary Name | Zelapar |
| Package Description | 6 POUCH in 1 CARTON (0187-0453-02) > 1 BLISTER PACK in 1 POUCH > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 0187-0453 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | selegiline hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060614 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals International |
| Substance Name | SELEGILINE HYDROCHLORIDE |
| Strength Number | 1.25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
